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Abstract
The goals in clinical and cohort studies often include evaluation of the association
of a time-dependent binary treatment or exposure with a survival outcome. Re-
cently, several impactful studies targeted the association between aspirin-taking and
survival following colorectal cancer diagnosis. Due to surgery, aspirin-taking value
is zero at baseline and may change its value to one at some time point. Estimating
this association is complicated by having only intermittent measurements on aspirin-
taking. Na¨ive, commonly-used, methods can lead to substantial bias. We present a
class of calibration models for the distribution of the time of status change of the
binary covariate. Estimates obtained from these models are then incorporated into
the proportional hazard partial likelihood in a natural way. We develop nonparamet-
ric, semiparametric and parametric calibration models, and derive asymptotic theory
for the methods that we implement in the aspirin and colorectal cancer study. Our
methodology allows to include additional baseline variables in the calibration models
for the status change time of the binary covariate. We further develop a risk-set
calibration approach that is more useful in settings in which the association between
the binary covariate and survival is strong.
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1 Introduction
One benefit of the Cox proportional hazards (PH) model for analysis of time-to-event
data (Cox 1972) is the simplicity of including time-dependent covariates, while preserving
desirable theoretical properties. Classical methods assume that time-dependent covariates
are measured continuously. However, in practice, they are often measured intermittently,
leading to bias in effect estimates if treated na¨ively (Andersen & Liestøl 2003, Cao et al.
2015). We consider a time-dependent binary covariate having zero value at baseline, that
may change its value to one at some point, and once a change has occurred, the covariate
retains this value for the rest of the follow-up time. Real-life scenarios of this nature are
widespread, including the onset of a irreversible medical condition (e.g., HIV infection,
Langohr et al. 2004) or a treatment with a constant effect that is administrated in a
different time for each patient (Austin 2012). For example, Goggins et al. (1999) described
data arising from a clinical trial where the goal was to study the effect of Cytomegalovirus
(CMV) shedding on risk of developing active CMV disease.
In the problems motivating this paper, the researchers were interested in the associa-
tion between regularly taking aspirin, henceforth simply referred to as aspirin-taking, and
the survival time following the diagnosis of colorectal cancer (CRC). A series of studies
published in leading clinical journals (Chan et al. 2009, Liao et al. 2012, Hamada et al.
2017) provided evidence for differential association between post-diagnosis aspirin-taking
and the survival time according to tumor subtype classification, which is a baseline variable
coded as a categorical variable. The main dataset was obtained from two cohort studies:
the Nurses’ Health Study (NHS) and the Health Professionals Follow-Up Study (HPFS).
Following their enrollment to the studies, participants have been receiving questionnaires
biennially and answering questions about life-style and other participants’ characteristics.
Patients diagnosed with colorectal cancer who had been taking aspirin typically stop tak-
ing aspirin at the time of diagnosis as part of their preparations to surgery. Post-diagnosis
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aspirin-taking is a time-dependent binary covariate, and the data about it is incomplete.
The time a participant started to take aspirin is known to lie within the interval between
the time of the last questionnaire answered as no aspirin-taking and the time of the first
questionnaire answered as aspirin-taking. A popular strategy is to replace unknown values
of the time-dependent covariate with the last available value. Another alternative is to
impute the change-time, the time of change in the covariate value from 0 to 1, using the
middle point of the observed interval.
There is little existing literature relevant to this statistical challenge. For time-to-event
data, Andersen & Liestøl (2003) studied the attenuation in effect estimates caused by
having infrequently measured covariates and, more recently, Cao et al. (2015) developed
kernel-based weighted score methods. Goggins et al. (1999) considered the problem of
interval-censored change-time of a binary covariate and proposed an EM algorithm to
estimate the association between the binary covariate and a survival time. Langohr et al.
(2004) developed a parametric log-linear survival model for the interval-censored change-
time problem. None of these methods allow to use covariates that are informative about
the change-time of the binary covariate.
In this paper, we propose a novel analysis framework for the problem of interval-censored
change-time and suggest a two-stage approach. In the first stage, we fit a model for the
status-changing time of the binary covariate. This model may be nonparametric, semi-
parametric or fully parametric, and may include baseline covariates that affect the change-
time. For this first stage, we exploit existing methods, theory and efficient algorithms for
interval-censored data (Sun 2007, Turnbull 1976, Finkelstein 1986, Huang 1996, Anderson-
Bergman 2016, Wang et al. 2016). In the second stage, we incorporate the first-stage
calibration model into the main PH model. We construct a partial likelihood using the
conditional hazard with respect to the available history, which, in the CRC and aspirin
dataset, includes the timing of the last questionnaire, corresponding aspirin-taking status
and baseline covariates.
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Unlike existing methods, our flexible approach allows to include variables potentially
related to the aspirin-taking status, utilizing the available data and subject-matter knowl-
edge in a novel way. In addition, participants without data about post-diagnosis aspirin
status, due to e.g., death or censoring before submitting answers for the first post-diagnosis
questionnaire, can be included in the analysis. Existing methods (e.g., Goggins et al. 1999)
exclude these participants from the analysis.
Our goal in this paper is three-fold. First, we develop a conceptual framework for
the analysis of time-to-event data under the common practice of infrequent updates of a
binary covariate of interest. Second, we present a rigorous analysis of data arisen from
several impactful studies in the area of colorectal cancer. Third, we provide the R package
ICcalib that implements our flexible methodology under a wide range of models.
The rest of the paper is structured as follows. In Section 2, we describe the motivating
studies. In Section 3, we define the main model, and in Section 4, we present our calibration
and risk-set calibration methods. Section 5 contains asymptotic properties where proofs
are deferred to the Appendix and the Supplementary Materials. In Section 6, we describe
our simulation study. In Section 7, we present the analysis of the CRC data and in Section
8, we reanalyze the CMV data of Goggins et al. (1999). We end with concluding remarks
in Section 9.
2 Data description
The data were formed from two large cohorts: the NHS, to which 121,701 female nurses
enrolled in 1976, and the HPFS that began in 1986 with the enlistment of 51,529 males
in various health professions. Description of the studies, the data collection process and
eligibility conditions for inclusion in the CRC survival studies can be found in Chan et al.
(2009), Liao et al. (2012) and Hamada et al. (2017).
Participants have been receiving questionnaires biennially. During each questionnaire
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cycle, participants returned their answers in varying times. CRC researchers are interested
in the first 5 or 10 years following the diagnosis since, conditionally on 10-year survival, the
survival rate among CRC patients is similar to the survival rate in the CRC-free population.
In our analyses, we considered 10 years follow-up. About 85% of stage 4 participants died
within the first 5 years (163 of 190), and 108 of them (57%) had no data on aspirin-taking.
Therefore, in order to not bias or destabilize the analysis results, we limited our analyses
to the 1,371 participants with stage 1-3 CRC or missing stage data. In the span of 10
years, 249 CRC-related deaths were observed among these participants. Table 1 presents
basic descriptive statistics of the main variables. Data on post-diagnosis aspirin use were
not available for 113 participants due to loss to follow-up or death before answering any
post-diagnosis questionnaire. Our methodology allowed us to include them in the analysis.
In the three CRC studies (Chan et al. 2009, Liao et al. 2012, Hamada et al. 2017),
evidence was presented for differential association of aspirin-taking with CRC mortality
across the following molecular subtypes, by considering the interaction terms of the aspirin-
taking status and these molecular subtypes. The three molecular subtypes were PTGS2
(cyclooxygenase-2) overexpression (Chan et al. 2009), PIK3CA mutation (Liao et al. 2012)
and low CD274 (PD-L1) expression (Hamada et al. 2017). These subtype definitions are
not exclusive; a tumor may be included in zero, one, two or three of these subtypes. The goal
of our analyses was to evaluate the association between post-diagnosis aspirin and CRC-
related mortality within the subpopulation of each tumor subtype. Therefore, each analysis
included different, although overlapping, subgroup of patients with the subgroup defined
by the molecular subtype for which evidence for aspirin effect was previously revealed. We
also included an analysis of all tumors, regardless of the tumor subtype classification.
The post-diagnosis time when diagnosed participants started taking aspirin varied. Fig-
ure 1 presents estimated time-to-start-taking-aspirin curves, for the entire sample (black,
middle curve) and by pre-diagnosis aspirin-taking status (red, top curve and blue, bottom
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Table 1: Summary of the main variables in the dataset
All Data low CD274 PIK3CA PTGS2
n (No. Events) 1371 (249) 278 (50) 171 (28) 672 (125)
Age at diagnosis: Mean (SD) 69.4 (9) 69.4 (8.97) 69.9 (9) 68 (8.73)
CRC Stage
I 375 (27%) 74 (27%) 55 (32%) 177 (26%)
II 453 (33%) 99 (36%) 62 (36%) 218 (32%)
III 387 (28%) 74 (27%) 44 (26%) 199 (30%)
Missing 156 (11%) 31 (11%) 10 (6%) 78 (12%)
Pre-diagnosis Aspirin Status
Taking 587 (43%) 118 (42%) 74 (43%) 272 (40%)
Non-taking 784 (57%) 160 (58%) 97 (57%) 400 (60%)
No. Available Questionnaires: Mean (SD) 3 (1.7) 3.1 (1.66) 3.2 (1.65) 3.3 (1.68)
No. Participants with no Questionnaires 113 21 11 47
curve). The figure depicts the non-parametric maximum likelihood estimator (NPMLE)
and the survival curve estimated assuming Weibull distribution, both calculated from the
interval-censored data about post-diagnosis aspirin-taking (Sun 2007). With the exception
of emergency surgeries, patients diagnosed with CRC were asked to stop taking aspirin to
prepare to the surgery, and were allowed to resume aspirin few days after the surgery. It is
likely that patients who had been taking aspirin prior to CRC diagnosis were more inclined
to start taking aspirin, once it was possible. This is consistent with the rapid drop right
after the baseline in the curve for pre-diagnosis aspirin-takers in Figure 1.
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Figure 1: Survival curve estimation of time to start-taking-aspirin for the entire sample
(in black, middle curve) and by pre-diagnosis (Predx) aspirin-taking status (takers vs non-
takers; bottom red vs top blue curves). Solid lines are the NPMLE, dashed lines are survival
curves obtained from Weibull model fitting.
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3 The main model
Let T be the time to event of interest, in the CRC data time-to-death following CRC diag-
nosis. T is possibly right censored by a censoring time C. We assume that, conditionally
on measured baseline covariates, T and C are independent, and let T˜ = min(T,C) and
δ = I{T < C} be the observed time and censoring indicator, respectively. Of main inter-
est is the association of the monotone nondecreasing binary covariate X(t) with T . For
presentational simplicity, we henceforth refer to X(t) as the exposure, although it can be
a treatment or any other binary covariate. Let V be the change time in the value of X.
That is, V is the first time when X(t) = 1. As described in the introduction, X(0) = 0
and X(t) = 1 for all t ≥ V . In some applications, the exposure may change its value back
to zero, at some point after V . In studying aspirin-taking this option is often neglected.
This is done to avoid misinterpretation of the results due to reverse causality, because de-
teriorating patients, who are more likely to die, may stop taking aspirin. In our study of
aspirin-taking and survival among CRC patients, we can therefore refer to the exposure as
ever aspirin-taking (since diagnosis).
Let Z be a column vector of covariates presumably associated with T . For simplicity
of presentation, we will assume that Z is time-independent. The proposed methods can be
straightforwardly applied to the scenarios when Z is time-dependent. The Cox PH model
(Cox 1972) for the hazard function of T given X(t) and Z is
λ(t|X,Z) = lim
∆→0
∆−1P (t ≤ T < t+ ∆|X(t),Z, T ≥ t) = λ0(t) exp(βX(t) + γTZ), (1)
where λ0(t) is an unspecified baseline function and β and γ are parameters to be estimated.
We are mainly interested in β. We refer to this PH model for λ(t|X,Z) as the main model.
We assume that, given Xi(t), {Xi(s), s < t} are not informative about the hazard at time
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t. The partial likelihood for (β,γ) is
L(β,γ) =
n∏
i=1
 exp(βXi(ti) + γTZi)n∑
j=1
Yj(ti) exp(βXj(ti) + γTZj)

δi
(2)
where Yi(t) = I{T˜i ≥ t} is an at-risk indicator.
If Vi was known for all i = 1, ..., n, we could simply set the time-dependent exposure to
be equal to zero for all t < V and to one after that time, i.e., Xi(t) = I{t ≥ Vi}. However,
the data collected from questionnaires are often limited. The aspirin-taking status Xi
was measured only at a series of Mi discrete time points: 0 = wi0 < wi1 < ... < wiMi ,
with X(wi0) = 0. If Xi was not measured at any time point before T˜i, then Mi = 0.
In the CRC data, these time points are the times when questionnaires were answered by
the participants. When the main event is terminal, as in our data, questionnaire data
available only until the event or censoring time; that is, wiMi ≤ T˜i. In other studies,
e.g., the CMV data previously analyzed by Goggins et al. (1999), data on the exposure
can be obtained even after the main event has occurred. The time points at which X was
measured are either fixed or random. We take a working assumption that their distribution
is independent of the other random variables presented so far. This assumption would not
hold in certain situations. The degree of the deviation from this assumption, and its impact
on the proposed methodology, will be discussed later in the paper.
Let wti denote the last time Xi was measured before time t; w
t
i = 0 if Xi was not
previously measured. If X(wti) = 1, then Xi(t) = 1. However, if X(w
t
i) = 0, then Xi(t)
can be either one or zero. Therefore, the likelihood (2) cannot be calculated from the
observed data. Two common methods for addressing this type of missing data are the
last-value-carried-forward (LVCF) and midpoint imputation (MidI) methods.
The LVCF method imputes missing values as the last observed values. In our context,
this is equivalent to setting Xi(t) = Xi(w
t
i). That is, a participant is assumed to not
taking aspirin, until the first time she reports aspirin-taking. The MidI method imputes
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the changepoint (i.e., V ) in the middle of the interval in which the changepoint is known
to have occurred. For example, if a participant reported she was not taking aspirin 1
year after diagnosis, and then reported taking aspirin 2.5 years after diagnosis, then MidI
would assume V = 1.75 for that participant; LVCF would assume V = 2.5. These are ad
hoc methods that may lead to substantially biased results. This calls for new conceptual
framework and methodology development, which we now present.
4 A calibration approach
Let Fit = {Zi,Qi, wti, Xi(wti), {Ti ≥ t}} be the history of an at-risk participant i until time
t, where Qi is a possibly vector-valued covariates informative about Xi(t), and {Ti ≥ t}
reflects the fact that participant i has been event-free so far. In our application,Qi includes,
among other covariates, the pre-diagnosis aspirin-use status, which is clearly informative
about Xi(t), as previously demonstrated in Figure 1. If a covariate affects both Ti and Xi,
it is included in both Zi and Qi.
Under model (1), the hazard function conditional on Fit is
λi(t|Fit) = lim
∆→0
∆−1P (t ≤ Ti < t+ ∆|Fit)
= lim
∆→0
∆−1EXi(t)|Fit [P (t ≤ Ti < t+ ∆|Ti ≥ t,Xi(t),Zi)]
= λ0(t) exp(γ
TZi)E
[
exp(βXi(t))|Fit
]
,
following the assumption that conditionally on Xi(t),Zi and {Ti ≥ t}, the probability of
event at time t is independent of Qi, w
t
i , and Xi(w
t
i).
A similar derivation was presented for the case of measurement error in a time-dependent
continuous covariate (Prentice 1982), and is exploited by the “regression calibration”
method (Wang et al. 1997, Ye et al. 2008, Liao et al. 2011). It is readily seen that λi(t|Fit)
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is also a PH model (Prentice 1982) and therefore we can consider the partial likelihood
LF(β,γ) =
n∏
i=1
 exp(γTZi)E
[
exp(βXi(ti))|Fiti
]
n∑
j=1
Yj(ti) exp(γTZj)E
[
exp(βXj(ti))|Fjti
]

δi
. (3)
Unlike the regression calibration method, the fact that Xi(t) is binary allows us to explicitly
write the expectation in (3) as
E
[
exp(βXi(t))|Fit
]
= 1 + P (Xi(t) = 1|Fit)(exp(β)− 1), (4)
where P (Xi(t) = 1|Fit) can be expressed using the distribution of V , the time of exposure
status change,
P (Xi(t) = 1|Fit) =

1 Xi(w
t
i) = 1
P (wti < Vi ≤ t|Qi, Ti ≥ t)
P (wti < Vi|Qi, Ti ≥ t)
Xi(w
t
i) = 0
. (5)
In words, the probability of a positive aspirin-taking status at time t, conditionally on the
personal history, equals to one, if the participant previously reported she is taking aspirin,
and if she did not report aspirin-taking previously, it equals to the probability of a change
in the aspirin-taking status between the last questionnaire time and time t, conditionally
on no aspirin-taking at time of last questionnaire. Combining (4) and (5), it is evident
that E
[
exp(βXi(t))|Fit
]
is a functional of the distribution of V conditionally on Qi and
{Ti ≥ t}. If the distribution of Vi|Qi, {Ti ≥ t} was known, we could have obtained valid
estimates for β and γ by substituting (4) and (5) into LF . However, the distribution of
Vi|Qi, {Ti ≥ t} is unknown.
Let Git be Fit without the survival information, i.e., Git = {Zi,Qi, wti, Xi(wti)}. Our first
proposal is to estimate β and γ by applying two modifications to LF . First, we replace F
by G in the expectations in (3) to get E[exp(βXi(t))|Git]. The second modification involves
replacing expectations of the form E
[
exp(βXi(t))|Git
]
by estimators Ê
[
exp(βXi(t))|Git
]
.
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Our ordinary calibration (OC) estimator βˆOC is the maximizer of
LG(β,γ) =
n∏
i=1
 exp(γTZi)Ê
[
exp(βXi(ti))|Giti
]
n∑
j=1
Yj(ti) exp(γTZj)Ê
[
exp(βXj(ti))|Gjti
]

δi
, (6)
with respect to β and γ. Noting the simplicity of this likelihood function, maximization
can be done in a straightforward way, e.g., using Newton-Raphson algorithm.
The expectation E
[
exp(βX(t))|Gt
]
can be expressed as a functional of the distribution
of V |Q, as in (4) and (5), with F replaced by G, and omitting {Ti ≥ t} in (5). Therefore,
we first estimate the distribution of V |Q, and then calculate Ê[exp(βXi(t))|Git] using the
estimated distribution.
4.1 Calibration models fitted from interval-censored data
For each participant, the data available on V include the previously mentioned measure-
ment times 0 = wi0 < wi1 < ... < wiMi , and the corresponding measurements. These data
can be summarized in a form of the interval V is censored into, denoted by (wiL, wiR],
where
wiL =
 0 Mi = 0 or X(wi1) = 1maxj{wij : X(wij) = 0} Mi > 0 & X(wi1) = 0 ,
wiR =
 minj{wij : X(wij) = 1} Mi > 0 & X(wiMi) = 1∞ Mi = 0 or X(wiMi) = 0 .
If wiL = 0, Vi is left-censored, and if wiR =∞, Vi is right-censored. Note that data about
measurements of Xi before wiL or after wiR do not add information about Vi.
We refer to the model for the distribution of V as the calibration model. Let SV (v) =
P (V > v) be the survival function of V . The general form of the likelihood of interval-
censored time-to-event data, under independent censoring assumption, is (Sun 2007)
LV =
n∏
i=1
P (wiL < Vi ≤ wiR) =
n∏
i=1
[SV (wiL)− SV (wiR)]. (7)
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The NPMLE estimator has been studied as an extension of the Kaplan-Meier estima-
tor to interval-censored data. Algorithms suggested to find the NPMLE include the self-
consistency EM algorithm (Turnbull 1976), the iterative convex minorant (ICM) algorithm
(Groeneboom & Wellner 1992), and an EM-ICM hybrid algorithm (Wellner & Zhan 1997).
Consistency and asymptotic distribution (at a n1/3 rate) were proved by Groeneboom &
Wellner (1992).
One can postulate a parametric or semiparametric model for the distribution of V . This
is especially appealing when the distribution of V is likely to depend on additional covari-
ates, previously denoted by Q. In the CRC studies, pre-diagnosis aspirin-taking status
is strongly associated with the time from CRC diagnosis to post-diagnosis aspirin-taking
(Figure 1). Additional covariates include risk factors for cardiovascular and cerebrovascu-
lar events because aspirin is often taken to reduce the risk of these events among high-risk
patients; see Section 7 for further discussion. Therefore, while our framework allows for va-
riety of time-to-event models, we focus in this paper on a calibration model with covariates,
and specifically a PH model of this nature.
Let η denote a vector of parameters characterizing the distribution of V . An estimator
of η is obtained by maximizing the equivalent of (7) under a model for SV that possibly
accommodates the covariates. See Chapter 2 of Sun (2007) for discussion of parametric
models for interval-censored time-to-event data. A more flexible model is a PH regression
model with an unspecified baseline hazard function. Finkelstein (1986) discussed PH mod-
els for interval-censored data and suggested discretization of the baseline hazard function.
Algorithms for computation of the MLE were previously proposed (Huang 1996, Huang
& Wellner 1997, Pan 1999), and asymptotic theory was studied (Huang 1996, Huang &
Wellner 1997). Cai & Betensky (2003) developed a related method for fitting PH models
from interval-censored data using a linear spline model for the log-baseline hazard and
maximized a penalized log-likelihood.
We adopt the recently developed framework of Wang et al. (2016), which uses flexible
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I-splines (Ramsay 1988) for the cumulative baseline hazard function. Wang et al. (2016)
further developed a fast EM algorithm, which we apply in our simulations and data analysis.
Let ΛV0 (v) and S
V
η,ΛV0
(v|Q) be the cumulative baseline hazard function and the survival
function of V , respectively, which under the PH model are
SVη,ΛV0
(v|Q) = exp[−ΛV0 (v) exp(ψTQ)],
ΛV0 (v) =
K∑
k=1
αkbk(v),
(8)
where for all k = 1, ..., K, αk ≥ 0 are unknown parameters to be estimated and bk(v) ∈ [0, 1]
are integrated spline basis functions, that are nondecreasing. The spline basis functions are
calculated according to the user specification of m interior knots and a polynomial degree
for the basis functions. The resulting ΛV0 (v) is guaranteed to be monotone increasing. See
Ramsay (1988) and Wang et al. (2016) for further details and discussion about I-splines
in general and for the PH model, respectively, including the important practical issues of
choosing the number and the location of the knots.
To summarize this section, the calibration model is fitted by maximizing the likelihood
(7) while substituting a model for SV , chosen based on the available data and subject-
matter knowledge. In our case, we are going to use the PH model (8) for the time until
aspirin-taking following a CRC diagnosis.
4.2 Risk-set calibration
The OC estimator βˆOC may suffer from asymptotic bias. It is calculated as the maximizer of
LG while the partial likelihood is LF . The degree of divergence between LF and LG depends
on how different E
[
exp(βX(t))|Ft
]
and E
[
exp(βX(t))|Gt
]
are. Recall that Gt was defined
by omitting from Ft the event {T ≥ t}. If the probability of this event is close to one, as in
the case of rare events, the bias should be attenuated. If X has no effect on T , i.e., under
the null, X(t) is independent of {T ≥ t} and E[exp(βX(t))|Ft] = E[exp(βX(t))|Gt]. This
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implies that as the absolute value of β0, the true value of β, increases, a larger bias may
be expected.
Another source of bias stems from fitting the calibration model under the independent
interval-censoring assumption, which is the assumption that wiL and wiR are independent
of Vi. However, in our studies, the time to event, T , is informative about the censoring in
the calibration model. If, for example, X reduces the risk of death, the time of aspirin-
taking status change is more likely to be censored in non-aspirin-taking patients. This
may cause bias in the estimation of η when fitting the calibration model. As before, if the
event is rare, the censoring of V is most likely due to administrative reasons, and hence
the independent interval-censoring assumption approximately holds. Furthermore, under
the null, the censoring interval is independent of V . As before, larger |β0| typically implies
more substantial bias. We investigate this point in the simulation studies in Section 6
and the Supplementary Materials. In studies with non-terminal event, the independent
censoring assumption for the calibration model may be more plausible, because data on X
can be collected after the main event has occurred.
In order to reduce potential bias, we propose a risk-set calibration (RSC) procedure, an
adaption of risk-set regression calibration previously developed in the context of error-prone
covariates in survival analysis (Xie et al. 2001, Ye et al. 2008, Liao et al. 2011). This method
uses LF , and estimate the distribution of V |Q, T ≥ t by refitting the calibration model for
V |Q at each observed event time, using only the members of the risk set at that time, so
only participants with T ≥ t are used. Then, at each risk set, we plug-in the estimated
distribution of V |Q, T ≥ t in (5), leading to P̂ (X(t)|Ft) which is then substituted in (4)
to obtain Ê
[
exp(βX(t))|Ft
]
for LF .
The RSC is expected to lead to less bias than OC, especially when |β0| is large (Xie
et al. 2001). However, some asymptotic bias in the RSC estimator may be expected, due to
model misspecification. Even if the PH model for the distribution of V |Q, T ≥ t holds at
t = 0, it is not expected to hold for all t > 0. The RSC estimator is also expected to have
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larger variance, due to increased number of parameters, and the decreasing (in t) sample
size for the risk-set calibration models. Therefore, it is advised to use this estimator when
the X-T association is strong, and the sample size is large.
5 Asymptotic properties
We focus on the PH model under the I-splines representation for ΛV0 of Wang et al. (2016).
The results can be straightforwardly extended to parametric models for SV . Let θ = (β,γ)
and η = (ψ,α) and recall that βˆOC is obtained by maximizing L
G, or alternatively, by
solving UG(θ, ηˆ) = 0 where
UG(θ;η) =
1
n
n∑
i=1
τ∫
0
[
ai(θ,η, t)− S
(1)(θ,η, t)
S(0)(θ,η, t)
]
dNi(t),
with τ being the study end-time, Ni(t) the counting process associated with Ti, and ai, S
(0)
and S(1) are as defined in the Appendix. Under assumptions (A1)–(A5) in the Appendix,
θˆOC
P−→ θ?. The proof is outlined in the Appendix. Furthermore, √n(θˆ − θ?) D−→ N(0,V)
and V can be estimated by a sandwich estimator
Vˆ = [−∇θUGθ(θˆOC , ηˆ)]−1
(
1
n
n∑
i=1
rˆi(θˆOC , ηˆ)rˆ
T
i (θˆOC , ηˆ)
)
[−∇θUGθ(θˆOC , ηˆ)]−1 (9)
with rˆi being a sample version of ri given in the Appendix. The proof is outlined in the
Appendix.
For the RSC estimator, results of similar nature are given and proved in the Supple-
mentary Materials. Main modifications in the results are that θˆRSC
P−→ θ??, where θ?? is
possibly different from θ?, and that η is replaced by η˜(t), a time-dependent parameter
vector.
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6 Simulation study
We considered a PH calibration model in our main simulation study. In the Supplementary
Materials, we describe simulation studies for parametric and nonparametric calibration
models in absence of covariates for calibration.
For the main model, the hazard function of T was λ0(t) exp(βX(t) + γ1Q1 + γ2Q2 +
γ3Z3), with Q1 ∼ Bernoulli(0.5), Q2 ∼ N(0, 0.52) and Z3 ∼ N(0, 1), all independent
of each other. We took the Gompertz baseline hazard function λ0(t) = 0.1 exp(0.25t),
and γ1 = log(0.75), γ2 = log(2.5) and γ3 = log(1.5). For β, we considered the values
β = log(1), log(2), log(5), log(7). We simulated time-to-event data with time-dependent
covariate as described in Austin (2012). We took exponential censoring (mean=5) and
additional censoring at time 5. The resulting censoring rate varied between 42% and 63%,
depending on the value of β.
For the calibration model, we used the setup of Wang et al. (2016), with SV (v) =
exp[(log(1 + v) +
√
v) exp(η1Q1 + η2Q2)], where η1 = log(2), η2 = log(0.5), and Q1 and Q2
are the same covariates as in the main model. For each observation, M? questionnaire time
points were simulated from the intervals on the equally spaced grid of [0, 5]. For example,
under M? = 2, the first questionnaire time point was simulated from U(0, 2.5), and the
second from U(2.5, 5). However, to mimic the motivating studies, we considered a terminal
main event, and kept only questionnaire time points before T˜i.
The PH calibration model fitting was done for each simulated dataset with m = 5
equally-spaced interior knots and a quadratic order for the basis functions of the I-spline
cumulative baseline hazard. In the CRC data analysis (Section 7), we have used the data
as recommended in Wang et al. (2016) to choose more carefully the number of knots, and
used cubic splines. Standard errors were estimated by (9) and confidence intervals were
calculated using the normal distribution.
We simulated 1000 datasets per scenario. Table 2 summarizes the results for the LVCF,
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the PH calibration model (PH-OC) and PH risk-set calibration models (PH-RSC), for
M? = 2, 5. Under the null, all three methods were valid. As the association between X
and T got stronger, a more substantial bias was observed. The OC estimator preformed
generally well, with increased bias and lower coverage rates of the 95% confidence interval
for the combination of β0 > log(2) and M? = 2. The RSC estimator had lower bias in
these scenarios. These observed biases were much smaller (in absolute value) than the bias
of the LVCF estimator.
Table A.1 in the Supplementary Materials presents more results from this simulation
scenario. It includes the results for M?i = 10, β = log(1/2), log(1/5), log(1/7), and the MidI
estimator. In terminal main event scenarios, MidI had a very large bias, even under the
null. This is because a finite interval is only observed for observations with left- or interval-
censored exposure times. Right-censored exposure times are dealt with differently (e.g.,
using LVCF) from left- or interval-censored observations, and a right-censored exposure
time is the result of the main event occurring before a change in X was observed. This
creates negative dependency between the imputed X and T˜ , even under the null. In studies
with non-terminal events, the MidI method is valid under the null, but not when β0 6= 0.
A small simulation study (not presented here) confirmed these claims.
To investigate the performance of our methods in other settings, we have considered
additional simulation studies without any covariates affecting the time-to-exposure (i.e., no
Q1 and Q2 in the calibration model) and compared Weibull and nonparamteric calibration
models when the true calibration model was Weibull, and when it was piecewise Expo-
nential. The results, presented in the Supplementary Materials, generally agreed with the
results we have descried in this section.
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Table 2: Simulation study results under a calibration PH model. Methods compared are LVCF, PH
calibration model (PH-OC) and PH risk-set calibration models (PH-RSC). We present mean estimates
(Mean), empirical standard deviations (EMP.SE), mean estimated standard errors (ŜE) and empirical
coverage rate of 95% confidence intervals (CP95%) for β. Results are based on 1000 simulated datasets
per scenario.
β0[exp(β0)] M? Method Mean EMP.SE ŜE CP95%
0.000 2 LVCF -0.002 0.141 0.135 0.944
[1.00] PH-OC 0.003 0.183 0.178 0.950
PH-RSC 0.004 0.183 0.177 0.952
5 LVCF 0.003 0.122 0.124 0.955
PH-OC 0.007 0.138 0.146 0.956
PH-RSC 0.007 0.138 0.142 0.956
0.693 2 LVCF 0.462 0.119 0.118 0.498
[2.00] PH-OC 0.680 0.175 0.179 0.936
PH-RSC 0.684 0.177 0.175 0.938
5 LVCF 0.572 0.107 0.110 0.810
PH-OC 0.690 0.132 0.145 0.958
PH-RSC 0.689 0.132 0.137 0.957
1.609 2 LVCF 0.968 0.110 0.109 0.000
[5.00] PH-OC 1.472 0.179 0.210 0.869
PH-RSC 1.516 0.190 0.195 0.897
5 LVCF 1.212 0.096 0.099 0.013
PH-OC 1.577 0.139 0.166 0.951
PH-RSC 1.575 0.137 0.151 0.948
1.946 2 LVCF 1.130 0.112 0.110 0.000
[7.00] PH-OC 1.695 0.182 0.230 0.723
PH-RSC 1.773 0.198 0.205 0.816
5 LVCF 1.410 0.097 0.098 0.000
PH-OC 1.890 0.148 0.187 0.933
PH-RSC 1.890 0.147 0.158 0.929
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7 Results of aspirin and CRC survival analyses
Our first step was to construct a calibration model. That is, a model for the time-to-start-
aspirin-taking. The 113 participants without available questionnaire data were not used
for fitting the calibration model, and the calibration model was fitted using the remain-
ing 1,258 participants. The baseline potential covariates included gender, age-at-diagnosis,
pre-diagnosis body mass index (BMI), pre-diagnosis aspirin-taking status, and the follow-
ing tumor characteristics: disease stage (1-3 and missing), differentiation (poor vs well-
moderate) and location (proximal colon, distal colon or rectum). We considered three PH
calibration models: (I) a model with all the aforementioned covariates, (II) a model with all
non tumor-related baseline covariates and disease stage, (III) a model with all non tumor-
related baseline covariates. Model (III) minimized the BIC (Schwarz 1978). In addition,
including strong determinant of the terminal event, such as disease stage, is undesired. An
association between disease stage and aspirin-taking could be the result of violation of the
independent censoring assumption for the calibration model. That is, the association of
the disease stage with aspirin-taking could be only due to the association of disease stage
with the censoring event, i.e., death.
Model (III) is logically sound from a subject-matter perspective. Aspirin is a preventive
care for patients in high-risk for vascular diseases. Therefore, determinants of vascular
diseases would also increase the probability of aspirin-taking. The covariates in Model (III),
age, gender, and BMI, are all well-established risk factors for vascular diseases. Therefore,
we adopted Model (III) as our calibration model. Table 3 presents the results of fitting this
PH model to the data. We used the same PH calibration model for all the analyses since
there is no reason to believe that the tumor subtype, that was not even known at the time
of diagnosis, informs the aspirin-taking status changing time.
As suggested by Wang et al. (2016), we used BIC to choose the number of equally-
spaced interior knots, which led to m = 11. We used the flexible cubic order for the spline
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Table 3: The PH calibration model for time-to-start-taking-aspirin, using cubic order and
m = 11 interior knots. Covariates include pre-diagnosis aspirin status (Predx-asp, taker
versus non-taker), pre-diagnosis BMI (Predx-BMI), age-at-diagnosis (Age-at-dx) and gen-
der (Female).
Est (ŜE) ĤR CI p-value
Predx-asp 1.14 (0.074) 3.11 [2.69, 3.60] < 0.001
Predx-BMI 0.03 (0.006) 1.03 [1.02, 1.04] < 0.001
Age-at-dx 0.01 (0.001) 1.01 [1.007, 1.013] < 0.001
Female -0.18 (0.073) 0.83 [0.72, 0.96] 0.013
basis functions. The number of interior knots according to the AIC criterion (Akaike 1974)
was m = 25. The final results did not substantially change when we specified m = 25
instead of m = 11 interior knots.
The simulation results presented in Section 6 and the Supplementary Materials have
shown that when there are covariates affecting the time-to-exposure, the PH-OC estimator
is preferable over the na¨ive methods, namely LVCF and MidI. Figure 2 illustrates the
difference between the methods. On its right panel, we drew the probabilities P̂ (Xi(t) =
1|history) versus t, for the first nine participants in our data, using LVCF, MidI, non-
parametric (NP) calibration, and the PH calibration model. Once Xi(t) = 1 was observed,
all methods assign P̂ (Xi(t) = 1|history) = 1 for the rest of the relevant risk sets. The left
panel of Figure 2 presents the same probabilities as the right panel of the figure, but for
the first participant only. This person did not report aspirin taking during the 10 years
follow-up (T˜ = 10). From the data, this person was a 75 years old (at diagnosis time)
male, that was taking aspirin at baseline. From Table 3, we would expect the probability
of this person to take aspirin to be higher than in the general population. This aligns with
this person having larger estimated probabilities under the PH model comparing to the NP
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Figure 2: P̂ (Xi(t) = 1|history) by the different considered methods for the first 9 partici-
pants. Panel (a) corresponds to the top left corner of Panel (b).
calibration model.
We included in the risk-set calibration models the covariates of Model (III). To avoid
destabilization of the calibration model fittings, we grouped the risk sets in intervals of size
0.5. That is, we refitted the calibration model every 6 months.
Turning to the main model, we included baseline covariates that are known to be associ-
ated with CRC-related death. These included age-at-diagnosis, pre-diagnosis BMI, family
history of CRC, and the following tumor characteristics: stage, differentiation and loca-
tion. Table 4 shows estimates and corresponding standard errors, confidence intervals, and
p-values for the association between aspirin-taking and survival in the three motivating
studies and in the entire data. Compared to LVCF, stronger protective associations were
estimated by our methods in all three subtype-specific analyses. Compared to the OC
estimates, the RSC estimates were only slightly further from null. This could be partially
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explained by the high censoring rate (>80%). Even though the sample sizes and case
numbers were low to moderate, there was evidence for strong protective effect of aspirin
for PIK3CA subtype CRC. The point estimates for aspirin in low CD274 subtype imply
negative association between aspirin and death, but, possibly due to limited power, the
null hypothesis was not rejected.
8 Reanalyzing the data in Goggins et al. (1999)
To our knowledge, the only non-na¨ive method developed for the problem of fitting a PH
model with interval-censored time-to-exposure was developed by Goggins et al. (1999).
Their motivated application was an analysis of AIDS Clinical Trial Group (ACTG) 181
(Finkelstein et al. 2002). The event of interest, active CMV disease, was non-terminal.
Their binary covariate was CMV shedding. Based on the joint likelihood for β and the
distribution of V (W in their notation), Goggins et al. (1999) proposed an EM algorithm
where the E-step is carried out with respect to the ordering of CMV shedding among the
study participants. They further developed a Gibbs sampler to improve computational
efficiency.
Our methodology has several improvements over the method of Goggins et al. (1999).
First, we exploit modern and fast estimation procedures for estimating the distribution
of V , by the NPMLE. Second, we can (but do not have to) include parametric modeling
assumptions on the distribution of V , if appropriate. Third, since we fit the calibration and
main models separately, we can include in our analysis participants without data about
the covariate of interest. Finally, and most importantly, we include measured covariates
affecting the time-to-exposure V .
We analyzed the ACTG 181 data (Finkelstein et al. 2002) using our method under
non-parametric calibration. The results are presented in Table ???? in the Supplementary
Materials. We observed a divergence between the OC and RSC estimates. The RSC
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Table 4: Results for the main model in the three CRC studies and in all data. Results presented
for the aspirin effect. The main model also included family history of CRC, pre-diagnosis BMI,
age-at-diagnosis, gender, disease stage, differentiation and location.
Study Method Est (SE) ĤR CI 95%(for HR) p-value
All Data LVCF -0.34 (0.147) 0.71 [0.53, 0.95] 0.020
(n = 1, 371) PH-OC -0.32 (0.176) 0.73 [0.51, 1.03] 0.072
(No. Events = 249) PH-RSC -0.32 (0.177) 0.73 [0.51, 1.03] 0.073
Low CD274? LVCF -0.64 (0.352) 0.53 [0.26, 1.05] 0.067
(n = 278) PH-OC -0.77 (0.400) 0.46 [0.21, 1.01] 0.054
(No. Events = 50) PH-RSC -0.79 (0.401) 0.45 [0.21, 1.00] 0.049
PIK3CA† LVCF -2.13 (0.639) 0.12 [0.03, 0.41] 0.001
(n = 171) PH-OC -2.22 (0.653) 0.11 [0.03, 0.39] 0.001
(No. Events = 28) PH-RSC -2.23 (0.657) 0.11 [0.03, 0.39] 0.001
PTGS2‡ LVCF -0.30 (0.202) 0.74 [0.50, 1.10] 0.138
(n = 672) PH-OC -0.32 (0.241) 0.73 [0.45, 1.16] 0.185
(No. Events = 125) PH-RSC -0.32 (0.241) 0.72 [0.45, 1.16] 0.181
? Hamada et al. (JCO, 2017)
† Liao et al. (NEJM, 2012)
‡ Chan et al. (JAMA, 2009)
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estimates were further away from the null, and similar to those obtained by Goggins et al.
(1999). The confidence intervals were quite wide, as one may obtain for hazard ratios of
strong effects when the sample size is moderate.
9 Conclusion
We have presented a novel calibration approach for studying the association between a
time-dependent binary exposure and survival time, when the data about the monotone
time-dependent exposure is only available intermittently. Our proposed approach allows
for wide range of calibration models. In practice, an adequate model should be chosen by
combination of subject-matter knowledge and the available data. The R package ICcalib
implementing our methods is publicly and freely available at blinded.
When the association between exposure and survival is strong, and a terminal event is
non-rare, our calibration framework may suffer from bias, that can be reduced, though not
eliminated, by risk-set calibration. Unlike regression calibration methods for error-prone
covariates, additional data (e.g., reliability or validation data) is not needed to fit the
calibration model, as the covariate measurements are inherently part of the data collected
to answer the question of interest.
The problem described in this paper and the proposed conceptual framework open the
way for further research. A main question of interest is whether β can be estimated consis-
tently from the data and what is the nature of further assumptions and methods to ensure
consistency. Our model is a type of a joint model for time-to-event and longitudinal data
(Tsiatis & Davidian 2004, Rizopoulos 2012). Potential alternative methods may include
developing joint modeling methods for binary longitudinal covariates (Faucett et al. 1998,
Larsen 2004, Rizopoulos et al. 2008) and adapting them to the problem of interval-censored
change-time. The bias in the calibration model can be tackled using methods for depen-
dent interval-censoring (Finkelstein et al. 2002). Another potential way to expand the
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research presented in this paper is to define alternative causal estimands and investigate
the identifiability assumptions needed to estimate parameters of interest.
In conclusion, we presented novel analyses to overcome a common problem in medical
and epidemiological research while presenting a new conceptual framework accompanied
by flexible and simple methodology to preform time-to-event analysis under the problem
of infrequently updated binary covariate.
SUPPLEMENTARY MATERIAL
Section A presents the asymptotic theory for the RSC, Section B describe our R package.
Additional simulation studies are described in Section C. Section D presents the analysis
results of the CMV data.
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Appendix
We first show that θˆ → θ?. Denote νθ,ηi (t) = EPη [exp(βXi(t))|Git] and ν0i (t) = EP0 [exp(β0Xi(t))|Git],
where for any η, EPη is the expectation under the PH model (8) for V , and EP0 is the
expectation under the true distribution. Denote also
S(m)(θ,η, t) =
1
n
n∑
i=1
[
Yi(t) exp(γ
TZi)ν
θ,η
i (t)ai(θ,η, t)
⊗m
]
s(m)(θ,η, t) = E[S(m)(θ,η, t)]
s(m)(η, t) = E
[
1
n
n∑
i=1
(
Yi(t)λ0(t) exp(γ
T
0Zi)ν
0
i (t)ai(θ,η, t)
⊗m
)]
where ai(θ,η, t) =
 exp(β)Pη [Xi(t)=1|Git]1+(exp(β)−1)Pη [Xi(t)=1|Git]
Zi
 and where for any vector x, x⊗0 = 1,x⊗1 =
x, and x⊗2 = xxT . Observe that λ0(t) exp(γT0Zi)ν
0
i (t) is the true hazard function (con-
ditionally on Git). Define also uGθ(θ;η) =
τ∫
0
s(1)(η, t)dt −
τ∫
0
s(1)(θ,η,t)
s(0)(θ,η,t)
s(0)(η, t)dt, and let
IGθ(θ,η) = ∇θuGθ(θ;η) and IGη(θ,η) = ∇ηuGθ(θ;η). We impose the following standard
regularity assumptions:
(A1) The number of knots K does not grow with the sample size n.
(A2) ηˆ
p−→ η?, for some η?.
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(A3) s(m)(θ,η, t),m = 0, 1, 2 are continuous and bounded functions of θ, for any θ and
η in the neighborhoods Θ and H of θ? and η?, respectively, and for all t ∈ [0, τ ].
Furthermore, s(0)(θ?,η?, t) is bounded away from zero.
(A4) The components of Zi are bounded for all i.
(A5) The matrix IGθ(θ,η
?) is continuous in θ and positive definite at θ?.
Assumption (A1) could be relaxed, see Wang et al. (2016). But for simplicity, we consider
(A1) as given above. By the Weak Law of Large Numbers, supt∈[0,τ ],θ∈Θ,η∈H |S(m)(θ,η, t)−
s(m)(θ,η, t)| p−→ 0. By the assumptions above and using arguments similar to those of
Andersen & Gill (1982) as implemented by Lin & Wei (1989), it follows that for any θ ∈ Θ
and η ∈ H, UGθ(θ;η)
p−→ uGθ(θ;η). Recall that θˆ is the solution of UG(θ; ηˆ) = 0 and
observe that
UGθ(θ; ηˆ) = U
G
θ(θ;η
?) + (UGθ(θ; ηˆ)−UGθ(θ;η?)) = UGθ(θ;η?) + op(1)
where the last equality holds by Assumption (A2) and since ai is bounded for finite values
of β. Let θ? be the solution of uGθ(θ;η
?) = 0. By the assumptions above, and specifically
Assumption (A5), θˆ
p−→ θ?. In particular, βˆ p−→ β?.
Regrading asymptotic normally, by a Taylor expansion
0 = UGθ(θˆ; ηˆ) = U
G
θ(θ
?;η?) + [∇θUGθ(θ?;η?)](θˆ−θ?) + [∇ηUGθ(θ?;η?)](ηˆ−η?) + op(n−1/2)
which can be rearranged as
√
n(θˆ−θ?) = [−∇θUGθ(θ?;η?)]−1
√
n{UGθ(θ?;η?)+ [∇ηUGθ(θ?;η?)(ηˆ−η?)]}+op(1). (10)
Similarly to Andersen & Gill (1982) and Lin & Wei (1989), by the assumptions given
above, ∇θUGθ(θ?;η?)
p−→ IGθ(θ?,η?), and by invoking similar arguments ∇ηUGθ(θ?;η?)
p−→
IGη(θ
?,η?). Let N (t) = E[n−1∑ni=1Ni(t)]. By arguments similar to those of Lin & Wei
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(1989), it can be shown that n1/2UGθ(θ
?;η?) = n−1/2
n∑
i=1
bi(θ
?;η?) + op(1), where
bi(θ;η) =
τ∫
0
[
ai(θ,η, t)− s
(1)(θ,η, t)
s(0)(θ,η, t)
]
dNi(t)
−
∫ ∞
0
Yi(t) exp(γ
TZi)ν
θ,η
i (t)
s(0)(θ,η, t)
[
ai(θ,η, t)− s
(1)(θ,η, t)
s(0)(θ,η, t)
]
dN (t) + op(1).
Regarding (ηˆ−η?), by Assumption (A1), it is a finite-size vector, and as explained in Wang
et al. (2016), it can be treated with the standard tools for parametric models. Denote
`V = logLV . By further incorporating standard theory of misspecified likelihood-based
models and Assumption (A2), we may write
√
n(ηˆ − η?) = −
(
1
n
n∑
i=1
∇ηη`Vi (η?)
)−1(
1√
n
n∑
i=1
∇η`Vi (η?)
)
+ op(1).
Substituting this in (10), we get
√
n(θˆ − θ?) = [−∇θUGθ(θ?;η?)]−1
(
1√
n
n∑
i=1
ri(θ
?,η?)
)
+ op(1)
where
ri(θ,η) = bi(θ,η)− [∇ηUGθ(θ;η)]
(
1
n
n∑
j=1
∇ηη`Vj (η)
)−1
∇η`Vi (η).
Therefore, by the multivariate central limit theorem and Slutsky’s theorem, we conclude
that
√
n(θˆ − θ?) is asymptotically normally distributed with covariance matrix
[IGθ(θ
?,η?)]−1E(ri(θ
?,η?)⊗2)[IGθ(θ
?,η?)]−1
which can be consistently estimated by Vˆ in Equation (9), by replacing parameters with
their estimates and expectations with their corresponding sample version.
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